Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02347202 · ClinicalTrials.gov registry record · NA

Tools for Distance Delivery of an Evidence-based AD Family Caregiver Intervention

A NA study of Dementia and Alzheimers Disease, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
135
Enrollment target
1
Study location

NCT02347202 is a NA study of Dementia and Alzheimers Disease that has completed, run by NYU Langone Health. The registered enrollment target is 135 participants, below the 7,722-participant average among 199 other Dementia trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02347202, a NA study of Dementia and Alzheimers Disease, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
135 participants
Enrollment target
1
Study location

Study Summary

A 20+ year randomized controlled trial (RCT) demonstrated the many benefits of a counseling and support intervention for spouse caregivers, the NYU Caregiver Intervention (NYUCI). The NYU Caregiver Intervention (NYUCI) is an evidence-based intervention that provides counseling and support for families involved in the care of a relative or friend with Alzheimer's Disease and Related Dementias (ADRD). Most notably, the NYUCI substantially reduced caregiver's depressive symptoms, improved their physical health, and extended the time persons with ADRD remained at home by an average of 1.5 years (Mittelman et al., AG14634, formerly MH42216; See http://www.ncbi.nlm.nih.gov/pubmed/17101889). The intervention is now being widely implemented in-person, but there are barriers that prevent many caregivers from receiving its benefits, including geographic distance; impediments to older adults leaving their homes; and travel considerations for counselors which make it impossible to provide the NYUCI in person. The goal of this study is to evaluate the efficacy of an online videoconferencing version of the NYUCI. This innovative application has massive implications for social service delivery to older adults, because it will make it possible to deliver an in-person intervention, via the internet, which is already evidenced based to older adult caregivers who cannot currently be served. It will create the online reservation and management technology linking counselors with families as well as the evidence of effectiveness of providing such services via secure video teleconferencing vehicles. The proposed Telehealth Technology for Distance Counseling (TTDC) and related online educational training modules will connect skilled providers to the families of persons with dementia without regard to geographic location. Implications for rural healthcare delivery are particularly persuasive. To the investigators knowledge, this will be the first large-scale TTDC to be developed and rigor

Interventions

  • OTHER Online counseling via Zoom teleconferencing
  • OTHER Telephone support as needed

Study Locations (1)

New York

  • NYU School of Medicine - New York

Trial Details

FieldValue
Enrollment Target 135 participants
Start Date 2015-10
Est. Completion 2020-03-04
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT02347202

The ClinicalTrials.gov registry entry for NCT02347202 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 135 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,722-participant average among 199 other Dementia trials with a reported enrollment target (98% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Dementia appearing as the primary indexed condition, and to 2 interventions - of which Online counseling via Zoom teleconferencing is the first listed.

NCT02347202 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02347202 about?

NCT02347202 is a clinical study titled "Tools for Distance Delivery of an Evidence-based AD Family Caregiver Intervention". A 20+ year randomized controlled trial (RCT) demonstrated the many benefits of a counseling and support intervention for spouse caregivers, the NYU Caregiver Intervention (NYUCI). The NYU Caregiver Intervention (NYUCI) is an evidence-based intervention that provides counseling and support for famili...

What is the current status of trial NCT02347202?

This trial is currently completed. It is a NA study. The enrollment target is 135 participants. The study started on 2015-10. Estimated completion is 2020-03-04.

What conditions does trial NCT02347202 study?

This clinical trial studies the following conditions: Dementia, Alzheimers Disease.

What interventions are being tested in trial NCT02347202?

The interventions under investigation include: Online counseling via Zoom teleconferencing (OTHER), Telephone support as needed (OTHER).

Who is sponsoring clinical trial NCT02347202?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02347202 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dementia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.